Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-methylacyl-CoA racemase pseudogene (ENSG00000219622) is a non-functional genomic DNA sequence related to the alpha-methylacyl-CoA racemase (AMACR) gene. Unlike the functional AMACR gene, which encodes a critical enzyme involved in branched-chain fatty acid metabolism, this pseudogene does not produce a functional protein and has no established biological or therapeutic relevance[6][7]. Pseudogenes are often formed by duplication or retrotransposition events and do not serve as drug targets, disease markers, or biomarkers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-methylacyl-CoA racemase pseudogene (ENSG00000219622).